Giorgio Walter Canonica

Innovative positioning of respiratory allergen immunotherapy: a focus on precision medicine

Introduction Allergen immunotherapy (AIT) is the only treatment for IgE-mediated respiratory allergy that can modify disease progression. Historically, AIT has relied on empirical personalization, based on allergen selection and clinical judgment. However, AIT is now transitionin...

Biosimilars in chronic spontaneous urticaria: current evidence, clinical implications and future perspectives

Chronic spontaneous urticaria (CSU) is a debilitating condition characterized by recurrent wheals and/or angioedema lasting more than six weeks without identifiable triggers. The global prevalence is increasing, and patients with resistance to antihistamine therapies experience a...